Former Pfizer CSO Mikael Dolsten joins board of gene editing startup
Mikael Dolsten, Pfizer's former chief scientific officer who led the company’s Covid-19 vaccine development, has joined the board of Arbor Biotechnologies, a gene editing startup working on therapies for liver and neurological diseases, Arbor told ...
Mikael Dolsten, Pfizer's former chief scientific officer who led the company’s Covid-19 vaccine development, has joined the board of Arbor Biotechnologies, a gene editing startup working on therapies for liver and neurological diseases, Arbor told ...
